General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Novo Nordisk Inc.(MODEST) RESEARCH/RESEARCH GRANTS: Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Roche Diagnostics(SIGNIFICANT), Novartis Corporation(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT)

View Full Disclosure